Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth

SIMPLE SUMMARY: Ovarian cancer survival rates are poor, with most deaths occurring from cancer recurrence following initial remission. Accordingly, there is a significant need for treatments that prevent relapse. Here, using a therapeutic vaccine against a mouse model of ovarian cancer, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Stump, Courtney T., Ho, Gregory, Mao, Chenkai, Veliz, Frank A., Beiss, Veronique, Fields, Jennifer, Steinmetz, Nicole F., Fiering, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915664/
https://www.ncbi.nlm.nih.gov/pubmed/33562450
http://dx.doi.org/10.3390/cancers13040627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915664/
https://www.ncbi.nlm.nih.gov/pubmed/33562450
http://dx.doi.org/10.3390/cancers13040627

Ejemplares similares